This website uses cookies to provide you with the best experience. By using this site you agree to our use of cookies. Please read our cookie notice for more information.

Investor Releases

Date Title View
05 March, 2019 ICON Wins Multiple Categories in 2019 CRO Leadership Awards
20 February, 2019 ICON Reports Fourth Quarter and Full Year 2018 Results
05 February, 2019 ICON Launches New Drug Safety Reporting Solution that Ensures Compliance through Automation
08 January, 2019 ICON Issues Financial Guidance for Full Year 2019
25 October, 2018 ICON Wins Pharma Contract Services Company of the Year at the Pharma Industry Awards 2018
24 October, 2018 ICON Reports Third Quarter 2018 Results
01 October, 2018 ICON Announces Release of ADDPLAN® neo
27 July, 2018 ICON Confirms Retirement of Co-Founder Dr. Ronan Lambe
25 July, 2018 ICON Reports Second Quarter 2018 Results
25 July, 2018 ICON Shareholders Vote in Favour of All Resolutions at its Annual General Meeting
27 June, 2018 ICON Is Collaborating with Practice Fusion, Inc. to Advance Health Research
11 June, 2018 ICON Enhances Endpoint Adjudication Services Using AG Mednet Advanced Technology
21 May, 2018 ICON launches FIRECREST Financial Disclosure to Reduce Administrative Costs and Increase Regulatory Compliance
16 May, 2018 ICON Named by Forbes as One of the Best Employers in America
09 May, 2018 ICON Sponsors Industry-Wide Clinical Trials Survey to Support Transforming Trials Initiative
02 May, 2018 ICON Reports First Quarter 2018 Results
17 April, 2018 ICON Announces Agreement with Intel Allowing Integration of the Intel® Pharma Analytics Platform for Clinical Trials
03 April, 2018 ICON Announces Launch of Government and Public Health Solutions to Support Global Public Health
15 February, 2018 ICON Reports Fourth Quarter and Full Year 2017 Results
09 January, 2018 ICON Issues Financial Guidance for Full Year 2018
Displaying 1 - 20 of 275

Search Investor